Remove Bioinformatics Remove Disease Remove Vaccine Remove Workshop
article thumbnail

Article FDA Thank You Leaders at FDA share highlights and updates for drugs and biologics at RAPS Convergence

Agency IQ

Joneckis said that CBER has “some limited uses that we have seen in external submissions, mostly in the bioinformatics area,” but not as many as CDER. Regarding artificial intelligence (AI), an important topic at RAPS Convergence, the two centers discussed external and internal use cases.

FDA 40
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

It has made its way into almost every aspect of drug discovery, whether it’s exploring basic biology, modelling diseases, identifying and validating targets, or performing drug screens. . One of the challenges we face with SARS-CoV-2 is that the virus continually evolves, making RNA vaccines and antibody therapies less effective.

DNA 246
article thumbnail

Is That DNA Dangerous?

Codon

A concerned employee at a laboratory supply company had called the Centers for Disease Control, or CDC, after fielding repeated calls from Harris asking when his samples of plague would arrive in the mail. 5 But it could match up to one of the threats in your reference database, so you opt to throw a battery of bioinformatics tools at it.

DNA 80